BKYI — BIO-key International Balance Sheet
0.000.00%
- $2.98m
- $2.57m
- $7.75m
- 18
- 31
- 20
- 12
Annual balance sheet for BIO-key International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.592 | 17.5 | 7.75 | 2.64 | 0.511 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.237 | 0.903 | 1.1 | 1.57 | 1.3 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1.37 | 18.9 | 14 | 8.98 | 2.62 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.662 | 0.569 | 0.323 | 0.305 | 0.257 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 2.5 | 22.5 | 17.8 | 11.3 | 4.52 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.39 | 1.88 | 2 | 5.46 | 3.21 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 4.78 | 2.19 | 2.15 | 6.04 | 3.45 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -2.29 | 20.3 | 15.6 | 5.3 | 1.06 |
Total Liabilities & Shareholders' Equity | 2.5 | 22.5 | 17.8 | 11.3 | 4.52 |
Total Common Shares Outstanding |